The trajectory of Sildenafil presents a challenging picture for investors. While the initial release generated significant profits, the expiration of its intellectual property protection opened the door to off-brand https://socialrus.com/story25251136/the-copyright-and-the-pharmaceutical-industry-a-volatile-bet